Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Radiation Protection Dosimetry|November 14, 2022
ESTIMATION OF FETAL AND PEDIATRIC DOSES FROM CHEST CT EXAMINATIONS USING VIRTUALDOSE SOFTWAREZirui Ye, Miao Qi, Yingming Zhao, et al.Radiation Protection Dosimetry|July 31, 2026
Calculation of neutron fluence-to-absorbed-dose conversion coefficients using Monte Carlo simulations and a pair of Chinese adult male and female phantomsKebede Shogile, Meitong Wei, Muhammad Zeeshan, et al.Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|February 27, 2026
Estimation of organ doses based on patient-specific characteristics undergoing chest-abdomen-pelvis CT examinations of tube current modulationBaohui Liang, Jing Wang, Zirui Ye, et al.Nucleic Acids Research|October 6, 2022
The novel type II toxin-antitoxin PacTA modulates Pseudomonas aeruginosa iron homeostasis by obstructing the DNA-binding activity of FurYingjie Song, Siping Zhang, Zirui Ye, et al.Journal of Molecular Medicine (Berlin, Germany)|September 23, 2023
Immunogenic necroptosis in liver diseases: mechanisms and therapeutic potentialZirui Ye, Nana Zhang, Hong Lei, et al.Iscience|June 17, 2024
Intracellular magnetic hyperthermia reverses sorafenib resistance in hepatocellular carcinoma through its action on signaling pathwaysHugang Li, Zirui Ye, Xun Wang, et al.Medical Physics|April 1, 2025
Uncertainty quantification for CT dosimetry based on 10 281 subjects using automatic image segmentation and fast Monte Carlo calculationsZirui Ye, Bei Yao, Haoran Zheng, et al.ACS Nano|October 21, 2024
Intracellular Magnetic Hyperthermia Sensitizes Sorafenib to Orthotopic Hepatocellular Carcinoma Via Amplified FerroptosisQianqian Tang, Yanyun Wang, Bin Yan, et al.Acta Biomaterialia|April 9, 2025
Dual-responsive magnetic vortex nanorings co-deliver lenvatinib and localized heat for synergistic activation of antitumor immunityZirui Ye, Bin Yan, Hugang Li, et al.World Journal of Surgery|July 9, 2026
Association of Pre-Transplant Tyrosine Kinase Inhibitor Therapy With Tumor Response and Survival in Hepatocellular Carcinoma: A 10-Year Retrospective Cohort Study of 427 PatientsLexuan Xu, Zixuan Zhao, Zichen Wang, et al.Pageof 1